Merieux Imovax Rabies ID
The lower-dose 0.1 ml version of Merieux Imovax rabies vaccine has been approved by FDA exclusively for pre-exposure immunization against rabies. The recommended dosage regimen is three intradermal doses with the second and third doses administered one week and three-four weeks after the initial dose. List price per unit will be approximately $25.
You may also be interested in...
Accord has launched its first monoclonal antibody biosimilar and fourth biosimilar overall, introducing in the UK the Zercepac version of trastuzumab developed by China’s Shanghai Henlius Biotech.
Novavax aims to recruit 10,000 subjects in the UK, and will include a flu vaccination co-administration for some participants.
Alvogen sister company Alvotech is continuing to extend its network of commercial partners by expanding its partnership with DKSH, a Swiss market expansion services group, for the commercialization of six biosimilars in Asian markets.